Mice and rats could be immunized against the polyoma-virus-induced tumor-specific transplantation antigen (TSTA) by repeated inoculation of frozen or irradiated cells of an MT-cDNA-transformed rat cell line (2.8) that contains only the polyoma middle T-antigen, or by cells that carried a host range
Immunization against the polyoma tumor-specific transplantation antigen (TSTA) with polyoma T-antigens
✍ Scribed by T. Ramqvist; D. O. Pallas; J. Deanda; L. Ährlund-Richter; G. Reinholdsson; T. M. Roberts; B. S. Schaffhausen; T. Dalianis
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- French
- Weight
- 648 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
The relationship between the pol yoma virus tumor-specific transplantation antigen (TSTA) and 2 of the virus proteins coded from the early region of polyomavirus was investigated. Mice were immunized with small T antigen and a truncated mutant of middle T antigen, both purified from genetically engineered Escherichia coli. The 2 proteins induced protective immunity against polyomavirus-induced tumors, but not against non-polyoma tumors, indicating that one or more of the polyoma T antigens are directly involved in a TSTA function.
📜 SIMILAR VOLUMES
Two polyoma-TSTA-negative variants were selected independently from a polyoma fibrosarcomdMoloney lymphoma somatic hybrid, by repeated passages in polyoma-virus-preimmunized mice. One of the variants had lost all its polyoma DNA, while the other only retained a deleted piece of its integrated polyom
## Abstract A protein factor which can be extracted from polyoma‐virus‐transformed BHK 21 cells is shown not to inhibit a virus‐coded early function (tumour antigen formation), whereas it inhibits the formation of the virus capsid antigen.
We have used 9 synthetic peptides corresponding to sequences of polyoma virus small-T, middle-T and large-T antigens as immunogens in order to map antigenic epitopes that can induce polyoma-tumor-specific immunity in different mouse strains. We found that immunization of mice with synthetic peptides
## Abstract We previously reported that inoculation of rats with live vaccinia virus (VV) recombinants VVpyMT, VVpyLT expressing either the middle‐T (MT) or large‐T (LT) proteins of polyomavirus (PyV) can elicit immunity to challenge with syngeneic PyV‐tumor cells. We now report the results of cros
## Abstract Specific cell‐mediated immunity to SV40 tumor‐specific transplantation antigen (TSTA) in BALB/c mice undergoing progressive tumorigenesis by syngeneic SV40‐transformed cells (VLM) was investigated in vivo using a tumor‐cell neutralization test. Specific cellular reactivity to SV40 TSTA